Bharti Airtel’s shares fell over 4% after Singtel reportedly offloaded a stake worth Rs 10,915 crore, sparking concerns among investors about the company’s future prospects.
Bharat Electronics Ltd. share price rebounded after the company received a major order worth Rs 6,650 crore from NTPC Ltd. for engineering, procurement, and construction work in Odisha.
GSK Pharma reported lower-than-expected revenue for Q2 FY26, but controlled costs resulted in improved profitability. Get the latest updates on the Indian stock markets and GSK Pharma’s performance.
Pine Labs Ltd. has launched its initial public offering with a price band of Rs 210–Rs 221 per share. Should you invest? Read our in-depth analysis for key details and expert insights.
Vodafone Idea is set to declare its Q2FY26 results next week. Check the date, earnings call schedule, and share price history to make informed investment decisions.
Piramal Finance has relisted on the stock exchanges at a 12% premium. Find out what this means for Indian investors and the broader implications for the NBFC sector.
Get the latest updates on MAS Financial Services’ Q2 performance, Axis Securities’ ‘Buy’ recommendation, and the outlook for the NBFC sector in India.
Astral Ltd.’s Q2 FY26 results were above estimates, but IDBI Capital downgraded the stock to ‘Hold’ due to limited upside potential. What does this mean for investors?
Get the latest updates on Updater Services’ Q2 results, Motilal Oswal’s downgrade, and its implications for Indian investors.
ICICI Securities has maintained its ‘Hold’ rating on Zydus Lifesciences Ltd. with a lower target price of Rs 900, citing a 4% downside. The company’s Q2 FY26 revenue was driven by recent acquisitions in consumer wellness and medtech divisions, but subdued margins and lower revenue of gRevlimid impacted Ebitda margin.